-
41
Topical neurokinin-1 receptor antagonism ameliorates ocular pain and prevents corneal nerve degeneration in an animal model of dry eye disease
Published 2025-02-01“…Ocular pain is a common complaint to eye care providers, associated with a variety of ocular conditions, among which dry eye disease (DED) is affecting millions of people worldwide. …”
Get full text
Article -
42
Dry Eye Disease following Refractive Surgery: A 12-Month Follow-Up of SMILE versus FS-LASIK in High Myopia
Published 2015-01-01“…Purpose. To compare dry eye disease following SMILE versus FS-LASIK. Design. …”
Get full text
Article -
43
AI-Based Advanced Approaches and Dry Eye Disease Detection Based on Multi-Source Evidence: Cases, Applications, Issues, and Future Directions
Published 2024-06-01Subjects: Get full text
Article -
44
Management of Graves’ upper eyelid retraction (GUER): A review
Published 2025-02-01Subjects: Get full text
Article -
45
-
46
Enhancing thyroid disease prediction and comorbidity management through advanced machine learning frameworks
Published 2025-12-01Subjects: Get full text
Article -
47
-
48
-
49
Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate
Published 2025-01-01Subjects: Get full text
Article -
50
Clinical efficacy of 0.1% cyclosporine A in dry eye patients with inadequate responses to 0.05% cyclosporine A: a switching, prospective, open-label, multicenter study
Published 2025-01-01Subjects: “…Dry eye disease…”
Get full text
Article -
51
-
52
‘It was like being hit with a brick’: a qualitative study on the effect of clinicians’ delivery of a diagnosis of eye disease for patients in primary and secondary care
Published 2022-07-01“…Objectives To explore patients’ experiences of getting a diagnosis of eye disease, the psychological impact of this and how this could be improved.Design An exploratory qualitative interview study using a narrative approach and inductive methods.Setting This study was conducted with patients who had attended ophthalmic appointments in primary and secondary care and in opticians located in the South of England.Participants 18 people diagnosed with eye disease in England.Results Four themes were identified: the convoluted process of being diagnosed, the impact of clinicians’ words, the search for information and reflections on what could be improved. …”
Get full text
Article -
53
Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics
Published 2025-01-01“…Abstract Perfluorohexyloctane ophthalmic solution (Miebo) and water-free cyclosporine ophthalmic solution 0.1% (Vevye) are recently approved treatments for dry eye disease (DED). Perfluorohexyloctane (PFHO) uses a novel approach to treat evaporative DED, whereas water-free cyclosporine (CsA 0.1%) is formulated to increase ocular delivery of its active ingredient to improve tear production. …”
Get full text
Article -
54
A Prospective, Crossover, Randomized, Double-Blind Clinical Study Comparing the Effectiveness and Ocular Comfort of 0.1% Hyaluronic Acid and 0.3% Hyaluronic Acid in Patients With Dry Eye Disease
Published 2025-02-01Subjects: “…dry eye disease…”
Get full text
Article -
55
Attendance of Patients with ophthalmological problems about Eye Protection from UV/blue Light Radiation from Sun light and Electronic Devices in Sulaimani City
Published 2018-07-01Subjects: “…Attendance, Eye disease, UV/Blue light radiation, Eye protection, Electronic devices,…”
Get full text
Article -
56
Dry eye post-cataract surgery: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…Dry eye disease…”
Get full text
Article -
57
-
58
Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Published 2025-01-01Subjects: Get full text
Article -
59
A curative effect evaluation of intensity-modulated radiation therapy combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease patients with active extraocular muscle but low CAS
Published 2025-01-01Subjects: “…Thyroid eye disease…”
Get full text
Article -
60
Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
Published 2024-09-01Subjects: Get full text
Article